Thalidomide and disease progression Patient Reports February 10, 2012
Thalidomide Side Effects Report #6001529-5
Thalidomide side effect was reported by a Physician from NEW ZEALAND on Dec 03, 2008. Male patient, weighting 149.9 lb, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: bone marrow disorder, disease progression, sepsis
, septic shock. Thalidomide dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, AMEPRAZOLE, TRANEXAMIC ACID, METFORMIN, OMEPRAZOLE, VENTOLIN, ATROVENT. Patient was hospitalized. Patient died on 11/19/2007.Thalidomide Side Effects Report #6064192-3
Thalidomide side effect was reported by a Physician from NEW ZEALAND on Jan 27, 2009. Male patient, weighting 149.9 lb, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression, sepsis
, septic shock. Thalidomide dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, AMEPRAZOLE, TRANEXAMIC ACID, METFORMIN, OMEPRAZOLE, VENTOLIN, ATROVENT. Patient was hospitalized. Patient died on 11/19/2007.Thalidomide Side Effects Report #4790795-X
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Aug 23, 2004. Male patient, 19 years of age, was diagnosed with sarcoma and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: 100 MG, DAILY, ORAL. During the same period patient was treated with MORPHINE. Patient died on 08/13/2004.
Thalidomide Side Effects Report #4922761-5
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Feb 08, 2006. Male patient, 69 years of age, was diagnosed with renal amyloidosis and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: anuria, blood creatinine increased, blood potassium increased, diarrhoea, disease progression, hypotension, infection
, lung infection, performance status decreased. Thalidomide dosage: 200 MG, DAILY, ORAL : 100 MG, DAILY, ORAL. During the same period patient was treated with NEXIUM, LASIX, LEXOTANIL, TEMESTA, PRIMPERAN, CODEINE, PAROXETINE. Patient was hospitalized. Patient died on 01/16/2006.Thalidomide Side Effects Report #5657522-5
Thalidomide side effect was reported by a Health Professional from UNITED STATES on Mar 07, 2008. Male patient, weighting 174.2 lb, was diagnosed with prostate cancer
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: bile duct obstruction, disease progression, international normalised ratio increased, jaundice
. Thalidomide dosage: 100MG ONCE A DAY PO. During the same period patient was treated with DOXIL. Patient was hospitalized. Patient recovered.Thalidomide Side Effects Report #4974576-X
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Mar 28, 2006. Female patient, 75 years of age, was diagnosed with plasmacytoma and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: bronchitis
, cardiac failure, disease progression, performance status decreased, pleural effusion, somnolence, systemic inflammatory response syndrome. Thalidomide dosage: 400 MG, QD, ORAL. During the same period patient was treated with OPIOIDS, BISPHOSPHONATES, IMMUNE GLOBULIN INTRAVENOUS. Patient was hospitalized. Patient died on 03/12/2006.Thalidomide Side Effects Report #4790807-3
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Aug 31, 2004. Male patient, 67 years of age, was diagnosed with plasmacytoma and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression, hypoaesthesia, paraesthesia, renal failure, sensory disturbance. Thalidomide dosage: unknown. Patient was hospitalized. Patient died on 08/20/2004.
Thalidomide Side Effects Report #4790237-4
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Jan 28, 2005. Male patient, 62 years of age, was diagnosed with plasmacytoma and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: 100 MG, DAILY, ORAL. Patient died on 10/01/2004.
Thalidomide Side Effects Report #4790238-6
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Feb 14, 2005. Male patient, 62 years of age, was diagnosed with plasmacytoma and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression, platelet count decreased, white blood cell count decreased. Thalidomide dosage: 500 MG, DAILY, ORAL. Patient died on 02/10/2005.
Thalidomide Side Effects Report #4790236-2
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Jan 24, 2005. Male patient, 68 years of age, was diagnosed with pancreatic carcinoma and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: 100 MG, QD, ORAL. Patient was hospitalized. Patient died on 01/16/2005.
Thalidomide Side Effects Report #4783068-2
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on May 03, 2005. Male patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, pulmonary embolism
. Thalidomide dosage: 150 MG, DAILY, ORAL. During the same period patient was treated with CARBOPLATIN, GEMCITABINE, QUININE SULPHATE, LORAZEPAM. Patient was hospitalized. Patient died on 05/03/2005.Thalidomide Side Effects Report #4783066-9
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Mar 11, 2005. Male patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression, pneumonia
, pneumonia staphylococcal. Thalidomide dosage: 100 MG, DAILY, ORAL. During the same period patient was treated with CARBOPLATIN, SIMVASTATIN, ENALAPRIL, AMLODIPINE, ATENOLOL, DEXAMETHASONE, OMEPRAZOLE. Patient was hospitalized. Patient died on 03/07/2005.Thalidomide Side Effects Report #4783061-X
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Feb 16, 2005. Male patient, 68 years of age, was diagnosed with non-small cell lung cancer and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, cough, disease progression, dyspnoea, gamma-glutamyltransferase increased, white blood cell count increased. Thalidomide dosage: 100 MG, DAILY, ORAL. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient died on 02/12/2005.
Thalidomide Side Effects Report #5308321-5
Thalidomide side effect was reported by a Health Professional from UNITED STATES on Apr 12, 2007. Female patient, 49 years of age, was diagnosed with myelofibrosis and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: cardiomegaly, disease progression, hepatosplenomegaly, myelofibrosis, pain
. Thalidomide dosage: 50-100 MG, DAILY, ORAL. During the same period patient was treated with COUMADIN, XANAX. Patient was hospitalized. Patient recovered.Thalidomide Side Effects Report #4790239-8
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on May 18, 2005. Male patient, 72 years of age, was diagnosed with myelodysplastic syndrome and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression, pneumonia
. Thalidomide dosage: 200 MG, DAILY, ORAL. During the same period patient was treated with LEFLUNOMIDE. Patient died on 06/02/2004.Thalidomide Side Effects Report #4790808-5
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Oct 11, 2004. Male patient, 60 years of age, was diagnosed with myelodysplastic syndrome and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: 400 MG, DAILY, ORAL. During the same period patient was treated with OMEPRAZOLE, HYOSCINE HYT, SPIRONOLACTONE, METOPROLOL TARTRATE, NEUPOGEN, ERYPO. Patient died on 10/09/2004.
Thalidomide Side Effects Report #5863195-9
Thalidomide side effect was reported by a Consumer or non-health professional from AUSTRALIA on Aug 20, 2008. Male patient, weighting 132.3 lb, was diagnosed with myelodysplastic syndrome, chronic obstructive pulmonary disease, constipation
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: atrophy, circulatory collapse, disease progression, loss of consciousness. Thalidomide dosage: unknown. During the same period patient was treated with VIDAZA, SERETIDE, COLOXYL, SENNA. Patient was hospitalized. Patient recovered.Thalidomide Side Effects Report #5918222-7
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Sept 26, 2007. Female patient, 83 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: 200 MG, 4 IN 1 D, ORAL. Patient died on 06/29/2007.Thalidomide Side Effects Report #4781962-X
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Jan 30, 2005. Male patient, 79 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression, pneumonia
. Thalidomide dosage: 200 MG, DAILY, ORAL. Patient died.Thalidomide Side Effects Report #4790240-4
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on May 24, 2005. Female patient, 79 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: 250 MG, DAILY, ORAL. During the same period patient was treated with DIZEPAM, FUROSEMIDE, PANTOPRAZOLE. Patient died on 05/01/2005.Thalidomide Side Effects Report #5918186-6
Thalidomide side effect was reported by a Physician from NEW ZEALAND on June 16, 2008. Male patient, 78 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: 50 MG DAILY ORAL. Patient died on 06/01/2008.Thalidomide Side Effects Report #4781943-6
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on July 28, 2004. Male patient, 77 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: 50 MG, DAILY, ORAL. Patient died on 01/01/2004.Thalidomide Side Effects Report #5706581-X
Thalidomide side effect was reported by a Health Professional from LEBANON on Apr 03, 2008. Male patient, 75 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression, hypotension, oedema, pain
, respiratory distress. Thalidomide dosage: 100 MG, DAILY, ORAL. Patient was hospitalized. Patient died on 03/21/2008.Thalidomide Side Effects Report #4695150-9
Thalidomide side effect was reported by a Physician from on June 13, 2005. Female patient, 75 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: anterior chamber disorder, conjunctival hyperaemia, corneal deposits, disease progression, hypopyon, iris adhesions, visual acuity reduced, vitritis. Thalidomide dosage: unknown. Patient died.Thalidomide Side Effects Report #4780823-X
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Sept 23, 2004. Male patient, 75 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression, neutropenic sepsis. Thalidomide dosage: 400 MG, DAILY, ORAL. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient died on 06/24/2004.Thalidomide Side Effects Report #5723212-3
Thalidomide side effect was reported by a Physician from UNITED STATES on Apr 18, 2008. Male patient, 74 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression, fall
, hip fracture, multiple myeloma
. Thalidomide dosage: 50-100MG, DAILY, ORAL. Patient died on 06/09/2007.Thalidomide Side Effects Report #5918116-7
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Oct 31, 2007. Male patient, 74 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: unknown. Patient died on 10/24/2007.Thalidomide Side Effects Report #4780827-7
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Dec 07, 2004. Male patient, 74 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: unknown. Patient died on 10/13/2004.Thalidomide Side Effects Report #5918220-3
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Sept 26, 2007. Male patient, 73 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: 100 MG, 2 IN 1 D, ORAL. Patient died on 07/18/2007.Thalidomide Side Effects Report #4790809-7
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Nov 02, 2004. Male patient, 73 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: cardiac enzymes increased, chest pain
, coagulation time abnormal, coronary artery disease
, cough, disease progression, dyspnoea, fall
. Thalidomide dosage: DAILY DOSE STEADILY INCREASED, THE LAST DOSE WAS 300MG, ORAL. During the same period patient was treated with VELCADE. Patient was hospitalized. Patient died on 10/03/2004.Thalidomide Side Effects Report #5519200-2
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Nov 05, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: abdominal distension, ascites, blood potassium increased, blood sodium decreased, cardiac arrest
, dialysis
, disease progression, gastrointestinal haemorrhage, hypertension. Thalidomide dosage: 100 MG, 2 IN 1 D, ORAL. Patient was hospitalized and became disabled. Patient died on 11/02/2007.Thalidomide Side Effects Report #5523141-4
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Nov 09, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: ascites, blood calcium decreased, blood potassium increased, blood sodium decreased, cardiac arrest
, dialysis
, disease progression, hypertension, lobar pneumonia. Thalidomide dosage: 100 MG, 2 IN 1 D, ORAL. Patient was hospitalized and became disabled. Patient died on 11/02/2007.Thalidomide Side Effects Report #5918221-5
Thalidomide side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 26, 2007. Female patient, 71 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: 100 MG, 2 IN 1 D, ORAL. Patient died on 02/18/2007.Thalidomide Side Effects Report #5715763-2
Thalidomide side effect was reported by a Pharmacist from UNITED STATES on Apr 10, 2008. Male patient, 70 years of age, weighting 165.3 lb, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: candida pneumonia, cardiac failure, disease progression, extradural haematoma, faecal incontinence, no therapeutic response, paraparesis, subdural haematoma, urinary incontinence
. Thalidomide dosage: 100 MG, 2 IN 1 D, ORAL. During the same period patient was treated with DEXAMETHASONE, BORTEZOMIB, PANTOPRAZOLE, MORPHINE, METAMIZOLE, AMIODARONE, ATORVASTATIN CALCIUM. Patient died on 03/31/2007.Thalidomide Side Effects Report #5642723-2
Thalidomide side effect was reported by a Health Professional from UNITED STATES on Feb 18, 2008. Male patient, 69 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, ascites, aspartate aminotransferase increased, blood lactate dehydrogenase increased, cardiac failure, disease progression, gamma-glutamyltransferase increased, gastroenteritis
. Thalidomide dosage: 400 MG, ORAL. During the same period patient was treated with NEORECORMON, ACYCLOVIR, ISOSORBIDE DINITRATE, BISOPROLOL FUMARATE, SIMVASTATIN, ENOXAPARIN, TILIDIN, AREDIA. Patient died on 02/03/2008.Thalidomide Side Effects Report #5918224-0
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Oct 16, 2007. Female patient, 68 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: 100 MG, DAILY, ORAL. Patient died on 10/03/2007.Thalidomide Side Effects Report #4790794-8
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Aug 09, 2004. Male patient, 68 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: anaemia, disease progression, thrombocytopenia. Thalidomide dosage: 200 MG, DAILY, ORAL. Patient died on 02/02/2004.Thalidomide Side Effects Report #5474545-X
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Sept 21, 2007. Female patient, 67 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: asthenia, back pain
, disease progression, paraparesis, somnolence, stupor. Thalidomide dosage: 100 MG, 2 IN 1 D, ORAL. Patient died on 09/20/2007.Thalidomide Side Effects Report #5485955-9
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Sept 28, 2007. Female patient, 67 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: anorexia, asthenia, back pain
, disease progression, inflammation, light chain analysis increased, paraparesis, refusal of treatment by relative, somnolence. Thalidomide dosage: 100 MG, 2 IN 1 D, ORAL. Patient died on 09/20/2007.Thalidomide Side Effects Report #4780822-8
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Sept 02, 2004. Female patient, 67 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: 150MG-400MG, DAILY, ORAL. Patient died.Thalidomide Side Effects Report #4781951-5
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Nov 05, 2004. Female patient, 67 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: 50 MG, DAILY, ORAL. Patient died on 11/04/2004.Thalidomide Side Effects Report #4790246-5
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on June 29, 2005. Female patient, 67 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression, renal failure. Thalidomide dosage: unknown. During the same period patient was treated with ANTIHYPERTENSIVES, ANTICOAGULATION AGENT, BISPHOSPHONATES. Patient died on 06/27/2005.Thalidomide Side Effects Report #5706578-X
Thalidomide side effect was reported by a Health Professional from LEBANON on Apr 04, 2008. Male patient, 66 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: coma uraemic, disease progression, renal failure. Thalidomide dosage: 100 MG, DAILY, ORAL. During the same period patient was treated with ZOLEDRONIC ACID. Patient died on 03/23/2008.Thalidomide Side Effects Report #4780826-5
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Nov 08, 2004. Female patient, 65 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: unknown. Patient died on 10/28/2004.Thalidomide Side Effects Report #4599948-7
Thalidomide side effect was reported by a Physician from on Feb 21, 2005. Male patient, 64 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: anuria, disease progression, hepatorenal failure, hyperkalaemia, jaundice
, malignant neoplasm progression, pain
, pyrexia, somnolence. Thalidomide dosage: 50 MG, DAILY, ORAL. During the same period patient was treated with DEXAMETHASONE, ERYTHROPOIETIN, ZOLOFT, HYDROCHLORIDE, MORPHINE. Patient died on 01/29/2005.Thalidomide Side Effects Report #5918223-9
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Oct 16, 2007. Female patient, 62 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: 200 MG, DAILY, ORAL. Patient died on 10/05/2007.Thalidomide Side Effects Report #4781948-5
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Oct 22, 2004. Male patient, 62 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression, pneumonia
, sepsis
. Thalidomide dosage: 50 MG, DAILY, ORAL. Patient died on 10/14/2004.Thalidomide Side Effects Report #5918114-3
Thalidomide side effect was reported by a Health Professional from UNITED KINGDOM on Oct 30, 2007. Male patient, 58 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: 100 MG, DAILY, ORAL. Patient died on 10/25/2007.Thalidomide Side Effects Report #4781939-4
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on July 29, 2004. Male patient, 58 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: unknown. Patient died on 01/01/2004.Thalidomide Side Effects Report #5413887-0
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Aug 01, 2007. Male patient, 57 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression, multiple myeloma
, septic shock. Thalidomide dosage: 50 MG, QD, ORAL. Patient died on 07/01/2007.Thalidomide Side Effects Report #4656638-X
Thalidomide side effect was reported by a Health Professional from on Apr 25, 2005. Female patient, 57 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: cardiac failure, disease progression, pulmonary hypertension
, syncope, tricuspid valve incompetence. Thalidomide dosage: 400 MG, QD, ORAL. Patient died on 12/06/2001.Thalidomide Side Effects Report #5918113-1
Thalidomide side effect was reported by a Health Professional from UNITED KINGDOM on Oct 30, 2007. Male patient, 56 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: 200 MG, DAILY, ORAL. Patient died on 10/23/2007.Thalidomide Side Effects Report #5918170-2
Thalidomide side effect was reported by a Health Professional from UNITED STATES on Nov 15, 2007. Female patient, 56 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: 200 MG, QD, ORAL. Patient died on 11/05/2007.Thalidomide Side Effects Report #5918115-5
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Oct 30, 2007. Male patient, 50 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: 200 MG, 4 IN 1 D, ORAL. Patient died on 10/28/2007.Thalidomide Side Effects Report #5918159-3
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Oct 31, 2007. Male patient, 49 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: 50 MG, 1 IN 1 D, ORAL. Patient died on 10/20/2007.Thalidomide Side Effects Report #5705958-6
Thalidomide side effect was reported by a Health Professional from UNITED STATES on Apr 04, 2008. Male patient, 48 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression, renal failure. Thalidomide dosage: 100 MG, QD, ORAL. During the same period patient was treated with DEXAMETHSONE, ZOLEDRONIC. Patient died on 09/01/2007.Thalidomide Side Effects Report #4711114-0
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on June 27, 2005. Female patient, 47 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: coma, disease progression, paraplegia, sepsis
, spinal cord compression. Thalidomide dosage: 100 MG, DAILY, ORAL. Patient was hospitalized. Patient died on 02/04/2005.Thalidomide Side Effects Report #5070133-8
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on July 18, 2006. Female patient, 45 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression, epistaxis, leukaemia plasmacytic, thrombocytopenia. Thalidomide dosage: 200 MG, 1 IN 1 D, ORAL. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient died on 07/06/2006.Thalidomide Side Effects Report #5918218-5
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Aug 29, 2007. Male patient, 45 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: 200 MG, QD, ORAL. Patient died on 02/18/2007.Thalidomide Side Effects Report #4699732-X
Thalidomide side effect was reported by a Physician from on June 14, 2005. Male patient, 44 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression, multiple myeloma
. Thalidomide dosage: MAXIMUM DOSE OF 600 MG. Patient died.Thalidomide Side Effects Report #4779673-X
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Aug 17, 2004. Male patient, 40 years of age, was diagnosed with multiple myeloma
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression, sepsis
. Thalidomide dosage: 150 MG, DAILY, ORAL. During the same period patient was treated with CONTALGIN, NEXIUM, THIAMIN, FUROSEMIDE, ZYPREXA. Patient died on 02/11/2004.Thalidomide Side Effects Report #4790247-7
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on July 13, 2005. Male patient, 45 years of age, was diagnosed with malignant melanoma and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: 50 MG, DAILY, ORAL. During the same period patient was treated with TEMOZOLOMIDE, DEXAMETHASONE, OLIBAN, FAMCICLOVIR, HEPARIN. Patient died on 07/12/2005.
Thalidomide Side Effects Report #5904746-5
Thalidomide side effect was reported by a Physician from UNITED STATES on Apr 29, 2008. Female patient, 70 years of age, was diagnosed with lung neoplasm malignant and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: 50 MG, QD, ORAL : 100 MG, QD, ORAL. Patient died on 11/05/2007.
Thalidomide Side Effects Report #4831978-X
Thalidomide side effect was reported by a Physician from GREECE on Nov 08, 2005. Female patient, 54 years of age, was diagnosed with light chain disease and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: bone neoplasm, brain neoplasm, bulbar palsy, disease progression, malignant neoplasm progression, meningeal disorder, multiple myeloma
, neuropathy. Thalidomide dosage: 300 MG, QD,. During the same period patient was treated with DEXAMETHASONE, DOXORUBICIN, VINCRISTINE. Patient died.Thalidomide Side Effects Report #4699746-X
Thalidomide side effect was reported by a Physician from on June 14, 2005. Female patient, 53 years of age, was diagnosed with light chain disease and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: condition aggravated, disease progression, graft versus host disease, light chain disease. Thalidomide dosage: MAXIMUM DOSE OF 200 MG., QD, ORAL. Patient died.
Thalidomide Side Effects Report #5357212-2
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on May 31, 2007. Male patient, 74 years of age, was diagnosed with leukaemia plasmacytic and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: blood immunoglobulin a increased, condition aggravated, disease progression, polyneuropathy, pulmonary hypertension
. Thalidomide dosage: 50 MG, 1 IN 1 D, ORAL. During the same period patient was treated with VELCADE, VINCRISTINE, BENDAMUSTIN, DEXAMETHASONE, ADRIAMYCIN PFS, LYRICA. Patient was hospitalized. Patient recovered.Thalidomide Side Effects Report #5392923-4
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on July 10, 2007. Male patient, 74 years of age, was diagnosed with leukaemia plasmacytic and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: condition aggravated, disease progression, polyneuropathy, pulmonary hypertension
. Thalidomide dosage: 50 MG, 1 IN 1 D, ORAL; ORAL. During the same period patient was treated with VELCADE, VINCRISTINE, BENDAMUSTIN, DEXAMETHASONE, ADRIAMYCIN PFS. Patient was hospitalized. Patient died on 06/01/2007.Thalidomide Side Effects Report #4790234-9
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Nov 15, 2004. Male patient, 52 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: anuria, ascites, disease progression, hepatic failure, hepatorenal syndrome, renal failure acute. Thalidomide dosage: 200 MG, DAILY, ORAL. During the same period patient was treated with LASIX, HYDROMED IN, TRANSTEC ITS, MORPHINE. Patient was hospitalized. Patient died on 11/06/2004.
Thalidomide Side Effects Report #4578424-1
Thalidomide side effect was reported by a Health Professional from on Feb 04, 2005. Male patient, 51 years of age, was diagnosed with glioblastoma multiforme and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression, performance status decreased. Thalidomide dosage: unknown. During the same period patient was treated with PROCARBAZINE. Patient died.
Thalidomide Side Effects Report #5700643-9
Thalidomide side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 09, 2008. Male patient, weighting 116.8 lb, was diagnosed with brain neoplasm, disease progression and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: depressed level of consciousness, disease progression, hydrocephalus
, pain
, respiratory rate increased, tachycardia. Thalidomide dosage: 150MG QHS PO. During the same period patient was treated with CELECOXIB, FENOFIBRATE. Patient was hospitalized. Patient died on 04/07/2008.Thalidomide Side Effects Report #5197642-5
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Dec 18, 2006. Male patient, 57 years of age, was diagnosed with blood alkaline phosphatase and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: arrhythmia
, arteriosclerosis, bradycardia, cardiac failure, cor pulmonale, coronary artery stenosis, disease progression, emphysema, hypoventilation. Thalidomide dosage: 100-400 MG, DAILY, ORAL (SEE IMAGE). During the same period patient was treated with RILUTEK. Patient died on 06/14/2006.Thalidomide Side Effects Report #4790235-0
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Dec 07, 2004. Female patient, child 11 years of age, was diagnosed with astrocytoma and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: unknown. Patient died on 10/07/2004.
Thalidomide Side Effects Report #5363148-3
Thalidomide side effect was reported by a Health Professional from UNITED STATES on June 18, 2007. Male patient, 59 years of age, was diagnosed with amyotrophic lateral sclerosis
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: asthenia, disease progression, dysphonia, dyspnoea, musculoskeletal stiffness, pulmonary function test decreased, vital capacity decreased. Thalidomide dosage: 400MG/DAY DAILY PO. Patient was hospitalized. Patient recovered.Thalidomide Side Effects Report #5201125-3
Thalidomide side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 22, 2006. Male patient, 57 years of age, was diagnosed with amyotrophic lateral sclerosis
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: arrhythmia
, arteriosclerosis, bulbar palsy, cardiac failure, cardiomegaly, cor pulmonale, coronary artery stenosis, disease progression, emphysema. Thalidomide dosage: 100-400MG, 1 IN 1 D, ORAL. During the same period patient was treated with RILUTEK. Patient died on 06/14/2006.Thalidomide Side Effects Report #5532242-6
Thalidomide side effect was reported by a Health Professional from UNITED STATES on Nov 29, 2007. Male patient, 54 years of age, was diagnosed with amyotrophic lateral sclerosis
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, ill-defined disorder. Thalidomide dosage: 300MG/DAILY. Patient was hospitalized. Patient died on 11/09/2007.Thalidomide Side Effects Report #4744692-6
Thalidomide side effect was reported by a Health Professional from UNITED STATES on Aug 12, 2005. Male patient, 47 years of age, was diagnosed with amyotrophic lateral sclerosis
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: amyotrophic lateral sclerosis
, constipation
, deep vein thrombosis
, disease progression, dysuria, micturition urgency. Thalidomide dosage: 400 MG/DAY. Patient was hospitalized. Patient recovered.Thalidomide Side Effects Report #4987360-8
Thalidomide side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 28, 2006. Male patient, 46 years of age, was diagnosed with amyotrophic lateral sclerosis
and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression, dysphagia, hypokalaemia, sinus tachycardia. Thalidomide dosage: 300 MG /DAY. Patient recovered.Thalidomide Side Effects Report #5159257-4
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Nov 08, 2006. Male patient, 64 years of age, was diagnosed with amyloidosis and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: amyloidosis, brain natriuretic peptide increased, disease progression. Thalidomide dosage: unknown. During the same period patient was treated with PREDNISOLONE, MELPHALAN. Patient was hospitalized. Patient recovered.
Thalidomide Side Effects Report #4916536-0
Thalidomide side effect was reported by a Health Professional from UNITED STATES on Feb 16, 2006. Male patient was diagnosed with acute myeloid leukaemia, myelodysplastic syndrome and was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression, respiratory distress, white blood cell count increased. Thalidomide dosage: 100MG BID PO. During the same period patient was treated with ARSENIC. Patient was hospitalized. Patient recovered.
Thalidomide Side Effects Report #5918175-1
Thalidomide side effect was reported by a Physician from UNITED STATES on Nov 26, 2007. Female patient, 74 years of age, was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: 100 MG DAILY ORAL. Patient died on 11/17/2007.
Thalidomide Side Effects Report #4790242-8
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on June 09, 2005. Male patient, 65 years of age, was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression, metastases to central nervous system. Thalidomide dosage: 200 MG, DAILY, ORAL. During the same period patient was treated with MORPHINE. Patient died on 05/29/2005.
Thalidomide Side Effects Report #4783071-2
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on June 14, 2005. Female patient, 63 years of age, was treated with Thalidomide. After drug was administered, patient experienced the following side effects: diarrhoea, disease progression, neutropenic sepsis, renal impairment. Thalidomide dosage: 100 MG, DAILY, ORAL. During the same period patient was treated with CARBOPLATIN, ETOPOSIDE, LANSOPRAZOLE, ATORVASTATIN, AMIODARONE, DEXAMETHASONE, LOPERAMIDE, BECLOMETHASONE. Patient was hospitalized. Patient died on 06/13/2005.
Thalidomide Side Effects Report #4780829-0
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Jan 07, 2005. Female patient, 59 years of age, was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: unknown. Patient died.
Thalidomide Side Effects Report #4779679-0
Thalidomide side effect was reported by a Physician from UNITED KINGDOM on Oct 13, 2004. Female patient was treated with Thalidomide. After drug was administered, patient experienced the following side effects: disease progression. Thalidomide dosage: unknown. During the same period patient was treated with OMEPRAZOLE, EMULAX, IMPUGAN, SELOKEN, ALLOPURINOL, ALVEDON. Patient died.
Thalidomide and disease progression 